Methylprednisolone Completed Phase 4 Trials for Migraine Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02847494Corticosteroids for Acute Migraine in the Emergency Department